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Abstract
Background: Despite the importance of chromosomal translocations in the initiation and/or
progression of cancer, a comprehensive catalog of translocation breakpoints in which these are
precisely located on the reference sequence of the human genome is not available at present.
Description: We have created a database that describes the genomic location of 1,225
translocation breakpoints in human tumors, corresponding to 247 different genes, using
information from publicly available sources. Junction sequences from reciprocal translocations
were obtained from 655 different references (either from the literature or from nucleotide
databases), and were mapped onto the reference sequence of the human genome using BLAST. All
translocation breakpoints were thus referred to precise nucleotide positions (949 breakpoints) or
gene fragments (introns or exons, 276 breakpoints) within specific Ensembl transcripts.
Conclusion: TICdb is a comprehensive collection of finely mapped translocation breakpoints,
freely available at http://www.unav.es/genetica/TICdb/. It should facilitate the analysis of sequences
encompassing translocation breakpoints and the identification of factors driving translocation
events in human tumors.
Background
Chromosome translocations are very important in the ini-
tiation and/or progression of cancer, and consequently a
high number of translocation events have been reported
in human tumors. An extensive amount of information
about all types of chromosome rearrangements in cancer
is stored in the Mitelman Database of Chromosome Aberra-
tions in Cancer [1], a public database available at the Can-
cer Genome Anatomy Project; however, this resource does
not provide molecular information beyond the name of
the genes involved in each rearrangement. Although the
precise genomic location of many translocation break-
points can be inferred from published reports and nucle-
otide databases, a single repository where breakpoints are
mapped onto the reference sequence of the human
genome is not available at present. Our aim was to create
such a database and provide a simple query interface,
hoping that it will become a useful resource for research-
ers interested in analyzing sequence features in the vicin-
ity of translocation breakpoints.
Construction and content
We downloaded a text file containing all "Molecular Biol-
ogy Associations" from the Mitelman Database of Chromo-
some Aberrations in Cancer [1], version August 2006. From
this file we extracted the HUGO identifiers of all genes
involved in reciprocal translocations, but not in deletions,
amplifications, inversions or more complex rearrange-
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mation from two published catalogs of genes rearranged
in cancer [2,3]. We excluded immunoglobulin and T-cell
receptor genes, since their breakpoint regions are already
extensively covered in specific databases [4]. The final list
consists of 298 genes that are involved in reciprocal trans-
locations in hematological, mesenchymal or epithelial
malignancies.
All gene models and sequences were obtained from
Ensembl [5], version 38.36 (April 2006). Ensembl provides
a high quality annotation pipeline [6] and stores all the
information in a MySQL database from which data can be
extracted automatically using the Application Program-
ming Interface (API) provided by the Ensembl project [7].
Using Perl scripts, we created a text file containing the
sequence of all alternative transcripts of the 298 genes,
splitting the exons and introns of each transcript into sep-
arate sequences in fasta format. This file was indexed with
formatdb, so that it could be used as a database for local
BLAST searches [8].
We next searched PubMed and Genbank in order to find
translocation junction sequences available in the public
domain for all 298 genes. We identified 655 different
sources of sequence data (Genbank records or biblio-
graphic references) and we inspected each one of them,
extracting translocation junction sequences from Genbank
records and from the text or the figures/tables of pub-
lished articles. This process yielded sequence data for 279
out of the 298 genes. All translocation junction sequences
obtained are either fusion mRNAs or genomic fusion
sequences.
The process by which translocation breakpoints were
mapped onto the reference sequence of the human
genome is outlined in Figure 1. Briefly, the local database
containing the complete sequence of the genes was que-
ried with each translocation junction sequence using
blastn [8]. All BLAST outputs were inspected by the same
database curator, in order to identify the specific intron or
exon involved in each fusion. In the case of translocations
for which genomic junction sequences were available,
BLAST identified the exact nucleotide position of each
breakpoint. When the query sequence was a fusion
mRNA, BLAST matched this sequence to the exons flank-
ing the putative intronic translocation breakpoint in each
partner gene, thus establishing the identity of the specific
introns involved in the translocation but not the exact
position of the breakpoint. In these cases we have
assumed that the breakpoint would be located in the
intron preceding (or following) the exons identified by
the BLAST search. The validity of this assumption is sup-
ported by the fact that 25% of these introns also contain
at least one other breakpoint mapped at the nucleotide
level.
Following the mapping strategy explained above we were
able to map 1,225 different breakpoints, resulting from
795 different translocation events in human tumors. Fur-
thermore, we could identify the position of 949 break-
points at the nucleotide level of resolution. The remaining
breakpoints are located to a specific fragment (an intron
or an exon), but the exact nucleotide position of the
breakpoint within the fragment is not known because
they were mapped from mRNA fusion sequences. All
these breakpoints are located in 414 unique fragments
(introns or exons) belonging to 247 genes [see Additional
file 2]. Ensembl annotations usually include several alter-
native transcripts for each gene. For this reason, each frag-
ment is referred to a specific Ensembl transcript. The choice
of transcript was based on the amount of evidence sup-
porting each annotation: we selected transcripts manually
annotated by the HAVANA group at the Wellcome Trust
Sanger Institute, whenever these were available, or tran-
scripts with an appropriate HUGO Gene Nomenclature
Committee (HGNC) symbol.
All HGNC gene symbols, Ensembl gene and transcript
identifiers, positions of breakpoints and fragment
sequences are stored in a MySQL database. The database
schema is outlined in Figure 2, which shows the structure
of the tables.
Utility and discussion
TICdb can be searched using a simple web form that
allows the user to query the database by gene names. Only
gene symbols approved by the HGNC are accepted; for
this reason we include a list of valid HGNC gene identifi-
ers, together with alternative aliases and a link to Entrez
Gene, that will enable users to check gene aliases and
HGNC approved names for their gene(s) of interest [see
Additional file 2]. This list can also be accessed via a link
to a page in which all HGNC names are hyperlinked, so
that clicking on any one of them will perform the data-
base search for that gene and take the user to the results
page. This link is clearly shown in all database pages.
Searching for a valid HGNC symbol returns a table show-
ing: i) a number identifying the fusion event; ii) for each
partner gene involved in the translocation: the HGNC
symbol, the description of the fragment harboring the
breakpoint, and the position of the breakpoint within that
fragment; and iii) the source of the junction sequence
used to map the breakpoints (a cross-reference to either a
Genbank or a PubMed record) hyperlinked to their respec-
tive databases. Clicking on any HGNC name in the results
page will perform a database search for that gene. Frag-
ment descriptions are in the form "ENSTX:IntronX", thatPage 2 of 5
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by the number of the intron (or exon) of that transcript
containing the breakpoint. Fragment names are hyper-
linked to Ensembl Exonview, so that the user can easily
download the sequence of the fragment and locate the
position of the breakpoint. Breakpoints derived from
fusion transcript sequences, not mapped at the nucleotide
level of resolution, are indicated as "breakpoint = 0". An
Excel table with all the records present in the database
sorted by gene names is provided [see Additional file 3]
and is also easily accessible from the web pages. Searching
with the wildcard "%" also returns all the entries in the
database.
In the results page, genes are listed as 5' or 3' partner
genes, depending on which part of the chimeric transcript
is contributed by each gene. In this respect, it should be
borne in mind that reciprocal fusion events frequently
result in the generation of two chimeric transcripts, each
corresponding to one of the translocated chromosomes.
However, the oncogenic effect of the translocation is usu-
ally attributed to one of the fusion transcripts. For this rea-
son, in these cases we consulted all Pubmed and Genbank
sources and arranged the partner genes in the position (5'
or 3') in which they appear in the fusion transcript most
likely to be responsible for the disease. It should be noted
Outline of the process of mapping translocation breakpointsFigur 1
Outline of the process of mapping translocation breakpoints. Each junction sequence obtained from the literature or nucle-
otide database (A) was blasted against a database (B) comprising the genomic sequence of all genes known to be involved in 
reciprocal translocations in human tumors. Inspection of the BLAST output (C) identifies the specific region of each gene 
involved in the translocation. In the case of genomic fusion sequences, like the one shown in A, BLAST also identifies the nucle-
otide position of the breakpoint on both translocation partner genes (C, right panels). In this example the breakpoints are 
located in nucleotide 8654 of intron 4 of ENST00000266427 (ETV6) and in nucleotide 230 of intron 15 of ENST00000381652 
(JAK2).Page 3 of 5
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different translocations.
The 414 unique fragments correspond to 378 introns and
36 exons, confirming that the vast majority of breakpoints
(91.3%) are located within introns and that transloca-
tions very rarely disrupt exonic sequences. This is further
supported by the fact that 15 of the exonic fragments that
contain a translocation breakpoint are either the first or
the last exon of the respective gene, with the breakpoint
either located in the untranslated regions or keeping most
of the coding sequence intact.
As mentioned before, all BLAST searches were manually
curated. Visual inspection of BLAST outputs is necessary
in order to resolve overlaps due to microhomologies,
small deletions and insertions, and to choose the Ensembl
transcript that is supported by a better annotation. This
affords a high quality of the data contained in TICdb, at
the cost of a rather time-consuming construction process.
For this reason, general upgrades of the database will be
performed only when a new NCBI build is released; regu-
lar updates including new information are much easier to
do and are planned every 6 months.
The information contained in this database can be used to
gain biological insights into the mechanisms leading to
chromosome translocations in cancer. For instance, we
have constructed a network of all the genes rearranged
[see Additional file 1]. The content and topology of this
network is very similar to that published by Höglund et al.
[9], and follows a power law degree distribution. Since the
network created by these authors was based on cytoge-
netic data, it has more nodes than our network. On the
other hand, the interactions between nodes in our net-
work are based on molecular data and so substantiate the
findings of Höglund et al. at the molecular level.
Most importantly, TICdb should be very useful to those
researchers trying to identify sequence motifs or func-
tional and structural features associated with the appear-
ance of a DNA double-strand break. Double-strand breaks
are the initiating lesions that trigger a chromosome trans-
location, and the probability that a genomic region sus-
tains a double-strand break might be dependent on its
sequence context. In fact, several studies have shown that
specific sequence motifs are significantly associated with
translocation breakpoints in selected genes in some tumor
types [10,11], but genome-wide studies have been hin-
dered by the lack of molecular data describing the loca-
tion of all published translocation breakpoints in all types
Schema of TICdb, showing the field-names and field-types for each table; underlined field names indicate primary keysFigure 2
Schema of TICdb, showing the field-names and field-types for each table; underlined field names indicate primary keys.Page 4 of 5
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of malignancies, which is precisely the information pro-
vided by TICdb. In this regard, we have previously ana-
lyzed a smaller version of this database and could identify
some structural features common to all translocations in
human cancer [12]. Analyses such as this were very chal-
lenging, since the data required to perform them are scat-
tered throughout several databases or in the literature. We
expect that TICdb will greatly facilitate this task and thus
become a useful resource in cancer genomics.
Conclusion
TICdb is a highly curated database containing a compre-
hensive catalog of translocation breakpoints in human
cancers. All these breakpoints are located to specific
introns or exons of Ensembl transcripts, many of them at
the nucleotide level of resolution. Thus, TICdb constitutes
an invaluable resource that should facilitate the analysis
of the sequences encompassing translocation breakpoints
in tumors.
Availability and requirements
TICdb is freely available at http://www.unav.es/genetica/
TICdb/ and has been optimized for Firefox 1.5 and Inter-
net Explorer 6.0.
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Additional File 1
A network graph showing all translocations included in TICdb, con-
structed using Cytoscape v2.3, showing 15 hubs (≥5 nodes/hub). The 
degree distribution (number of edges per node) follows a power law.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-33-S1.pdf]
Additional File 2
List of all 247 genes included in the database, showing the HGNC sym-
bol, the Ensembl Gene identifier and other aliases.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-33-S2.xls]
Additional File 3
A dump of the whole database, listing all 811 records sorted by the HGNC 
name of the 5' partner genes. Note that the same gene can be a 5' or a 3' 
partner gene, and that fusion numbers might be repeated if represented by 
two or more different cross-references.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-33-S3.xls]Page 5 of 5
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